ACCO Brands Corporation
NYSE:ACCOBusiness Equipment & Supplies
+$0.05 today
- Market cap
- $517.11M
- Beta
- 1.21
- P/E (TTM)
- 4.9
- EPS (TTM)
- $0.80
- Dividend yield
- 7.70%
Volume 1.77M
Average 1.07M
ACCO Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
ACCO Brands CorporationNYSE: ACCO
Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026
Other income / expenses turns positive
Q1 FY2026 other income / expenses was $25.3M, compared with -$10.1M a year earlier. Trailing-twelve-month other income / expenses was -$23.7M.
Context
- Other income / expenses amounted to 3.9% of revenue in FY2025, up 0.9 pp from a year earlier.
- Other income / expenses grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other income / expenses holds near $25.3M or moves back toward the trailing-twelve-month quarterly average of -$5.93M.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- (59.1M) USD
- Year-over-year change
- -17.5%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (59.1M) | -17.5% |
| FY2024 | 2024-12-31 | (50.3M) | +13.0% |
| FY2023 | 2023-12-31 | (57.8M) | -190.5% |
| FY2022 | 2022-12-31 | (19.9M) | +49.7% |
| FY2021 | 2021-12-31 | (39.6M) | — |
Other Income / Expenses vs competitors
How ACCO compares with its peers on the latest reported figures
- ACCO's LTM Mar 2026 other income / expenses of -$23.7M is the 6th highest of the 11 companies compared; the peer median is -$24.59M.
- Its year-over-year change of +51.8% is the 3rd highest of 11, against a peer median of -9.7%.
- Other income / expenses amounts to 1.5% of revenue for ACCO, versus a peer median of 4.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $130.15M | +934.7% | — | 204.9% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $8.47M | +10.5% | +60.0% | 5.0% |
| LTM Feb 2026 | $5.92M | +71.9% | — | 1.5% | |
| LTM Mar 2026 | -$4.28M | +28.9% | — | 0.8% | |
| LTM Mar 2026 | -$16.9M | -503.6% | — | 4.5% | |
| LTM Mar 2026 | -$23.7M | +51.8% | — | 1.5% | |
| LTM Apr 2026 | -$32.28M | -18.1% | — | 7.9% | |
| LTM Mar 2026 | -$36.84M | -76.4% | — | 2.5% | |
| LTM Mar 2026 | -$46.8M | -1.3% | — | 2.1% | |
| LTM Mar 2026 | -$59.1M | -41.4% | — | 3.7% | |
| LTM Mar 2026 | -$77M | -25.5% | — | 20.7% | |
| Peer median (excluding ACCO) | -$24.59M | -9.7% | +60.0% | 4.1% | |
Competitors are the stored peer set for ACCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.03B | 1.95B | 1.83B | 1.67B | 1.52B |
| Cost of Revenue | 1.41B | 1.4B | 1.23B | 1.11B | 1.07B |
| Gross Profit | 614.9M | 552.3M | 598.3M | 555.4M | 454.9M |
| Gross Margin | 30.4% | 28.4% | 32.6% | 33.3% | 29.8% |
| Research & Development | 26.6M | 26.3M | 25.8M | 23M | 22M |
| Selling, General & Admin | 392.6M | 376.7M | 395.3M | 371.8M | 324.7M |
| Operating Expenses | 463.9M | 517.5M | 553.6M | 592.4M | 346.7M |
| Depreciation & Amortization | 85.7M | 79.4M | 76.1M | 73.1M | 72.8M |
| EBITDA | 243.4M | 139.9M | 121.6M | 38.4M | 167.7M |
| EBITDA Margin | 12.0% | 7.2% | 6.6% | 2.3% | 11.0% |
| Operating Income | 151M | 34.8M | 44.7M | (37M) | 108.2M |
| Operating Margin | 7.5% | 1.8% | 2.4% | -2.2% | 7.1% |
| Interest Income | 1.9M | 8.3M | 7.1M | 7.5M | 9.4M |
| Interest Expense | 46.3M | 45.6M | 58.6M | 52.6M | 45.8M |
| Other Income / Expenses | (39.6M) | (19.9M) | (57.8M) | (50.3M) | (59.1M) |
| Income Before Tax | 111.4M | 14.9M | (13.1M) | (87.3M) | 49.1M |
| Pre-Tax Margin | 5.5% | 0.8% | -0.7% | -5.2% | 3.2% |
| Income Tax Expense | 9.5M | 28.1M | 8.7M | 14.3M | 7.8M |
| Net Income | 101.9M | (13.2M) | (21.8M) | (101.6M) | 41.3M |
| Net Margin | 5.0% | -0.7% | -1.2% | -6.1% | 2.7% |
| EPS (Basic) | 1.07 | (0.14) | (0.23) | (1.06) | 0.45 |
| EPS (Diluted) | 1.05 | (0.14) | (0.23) | (1.06) | 0.44 |
| Weighted Avg Shares | 95.5M | 95.3M | 95.3M | 95.6M | 92.1M |
| Weighted Avg Shares (Diluted) | 97.1M | 95.3M | 95.3M | 95.6M | 94M |
ACCO Brands Corporation
NYSE:ACCO
Intrinsic Alpha fair value
Locked
Current Price
$5.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.